Galectin Therapeutics Inc. / Fundamentals
Income statement
- Net revenue
€0.00 - Cost of goods sold
€10.30K - Gross profit
-€1.72K - SG&A expenses
€4.78M - R&D expenses
€24.41M - EBITDA
-€22.00M - D&A
€18.02K - EBIT
-€22.41M - Interest expenses
€2.83M - EBT
-€34.61M - Tax expenses
€0.00 - Net income
-€34.61M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€2.31M - Changes in working capital
-€1.33M - Operating cash flow
-€30.56M - Capex
€0.00 - Other investing cash flow
€0.00 - Net investing cash flow
€0.00 - Total cash dividends paid
-€68.64K - Issuance of common stock
€1.34M - Debt repayment
€9.44M - Other financing cash flow
€9.33M - Net financing cash flow
€20.41M - Foreign exchange effects
€0.00 - Net change in cash
-€10.15M - Cash at end of period
€11.82M - Free cash flow
-€30.56M
Balance sheet
- Cash and cash equivalents
€11.82M - Cash and short-term investments
€11.82M - Total receivables
€0.00 - Inventory
€0.00 - Other current assets
€1.42M - Total current assets
€13.24M - Property, plant & equipment
€0.00 - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€0.00 - Other non-current assets
€150.15K - Total non-current assets
€150.15K - Total assets
€13.39M - Accounts payable
€5.03M - Short-term debt
€44.62K - Other current liabilities
€4.17M - Total current liabilities
€9.24M - Long-term debt
€103.35M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€1.32M - Total non-current liabilities
€104.67M - Total liabilities
€113.92M - Common stock
€54.05K - Retained earnings
-€359.30M - Other equity
€0.00 - Total equity
-€100.53M - Total liabilities and shareholders' equity
€13.39M
Company information
- Market capitalization
€125.78M - Employees
15 - Enterprise Value
€184.03M
Company ratios
- Gross margin
-
0.0% - EBITDA margin
-
0.0% - EBIT margin
-
0.0% - EBT margin
-
0.0% - Net margin
-
0.0% - ROE
-
34.4% Much better than peer group: -110.9% - ROA
-
-258.6% Much worse than peer group: -90.8% - Asset turnover
-
0.0% - FCF margin
-
0.0% - FCF yield
-24.3% - Efficiency ratio
0.0% - Net sales per employee
-
€0.00 - Net income per employee
-
-€2.31M